Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Jul;40(7):2107-2111.
doi: 10.1007/s00467-024-06648-3. Epub 2025 Jan 9.

Bridging pediatric and adult IgAN: challenges in applying proteinuria-driven recommendations in the new IPNA guidelines

Alexandra Cambier  1   2 , Claire Dossier  3 , Anne-Laure Lapeyraque  4 , Véronique Phan  4 , Camille Laroche  4 , Karma Abukasm  4 , Genevieve Benoit  4 , Jean-Philippe Roy  4 , Julien Hogan  3 , Olivia Boyer  5 , Renato Monteiro  6 , Christophe Licht  7 , Paul Goodyer  8 , Mallory Downie  8 , Antonia Bouts  9 , Mounia Boutaba  10 , Tim Ulinski  11 , Stéphan Troyanov  12 , Mark Haas  13
Affiliations
Editorial

Bridging pediatric and adult IgAN: challenges in applying proteinuria-driven recommendations in the new IPNA guidelines

Alexandra Cambier et al. Pediatr Nephrol. 2025 Jul.
No abstract available

PubMed Disclaimer

References

    1. Vivarelli M, Samuel S, Coppo R, Barratt J, Bonilla-Felix M, Haffner D, Gibson K, Haas M, Abdel-Hafez MA, Adragna M, Brogan P, Kim S, Liu I, Liu ZH, Mantan M, Shima Y, Shimuzu M, Shen Q, Trimarchi H, Hahn D, Hodson E, Pfister K, Alladin A, Boyer O, Nakanishi K, International Pediatric Nephrology Association (2024) IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis. Pediatr Nephrol. https://doi.org/10.1007/s00467-024-06502-6 - DOI - PubMed - PMC
    1. Cambier A, Rabant M, El Karoui K, Peuchmaur M, Servais A, Hertig A, Deschenes G, Salomon R, Hogan J, Robert T (2020) Clinical and histological differences between adults and children in new onset IgA nephropathy. Pediatr Nephrol 35:1897–1905. https://doi.org/10.1007/s00467-020-04614-3 - DOI - PubMed
    1. Rauen T, Eitner F, Fitzner C, Sommerer C, Zeier M, Otte B, Panzer U, Peters H, Benck U, Mertens PR, Kuhlmann U, Witzke O, Gross O, Vielhauer V, Mann JF, Hilgers RD, Floege J, STOP-IgAN Investigators (2015) Intensive supportive care plus immunosuppression in IgA nephropathy. N Engl J Med 373:2225–2236 - DOI - PubMed
    1. Lv J, Wong MG, Hladunewich MA, Jha V, Hooi LS, Monaghan H, Zhao M, Barbour S, Jardine MJ, Reich HN, Cattran D, Glassock R, Levin A, Wheeler DC, Woodward M, Billot L, Stepien S, Rogers K, Chan TM, Liu ZH, Johnson DW, Cass A, Feehally J, Floege J, Remuzzi G, Wu Y, Agarwal R, Zhang H, Perkovic V, TESTING Study Group (2022) Effect of oral methylprednisolone on decline in kidney function or kidney failure in patients with IgA nephropathy: the TESTING randomized clinical trial. JAMA 327:1888–1898 - DOI - PubMed - PMC
    1. Kidney Disease: Improving Global Outcomes Glomerular Diseases Work Group (2021) KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int 100:S1–S276 - DOI

Publication types

LinkOut - more resources